TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bafna Pharmaceuticals Limited ( (IN:BAFNAPH) ) has shared an update.
Bafna Pharmaceuticals Limited has submitted its annual disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, to the stock exchanges. This disclosure, received from the company’s promoters, is a regulatory requirement that provides transparency about substantial share acquisitions and takeovers, ensuring stakeholders are informed about the company’s shareholding structure.
More about Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is based in Chennai, India, and is known for its commitment to quality and innovation in the healthcare sector.
Average Trading Volume: 1,038
Current Market Cap: 1.85B INR
For a thorough assessment of BAFNAPH stock, go to TipRanks’ Stock Analysis page.